rdf:type |
|
lifeskim:mentions |
|
pubmed:dateCreated |
2008-5-8
|
pubmed:abstractText |
To measure the oral bioavailability of estetrol (E(4)) in rats relative to its subcutaneous administration and to test the bone-sparing effect of oral E(4) compared to that of ethinylestradiol (EE).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1473-0804
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
11 Suppl 1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2-14
|
pubmed:meshHeading |
pubmed-meshheading:18464016-Administration, Oral,
pubmed-meshheading:18464016-Animals,
pubmed-meshheading:18464016-Area Under Curve,
pubmed-meshheading:18464016-Biological Availability,
pubmed-meshheading:18464016-Bone Density,
pubmed-meshheading:18464016-Bone Density Conservation Agents,
pubmed-meshheading:18464016-Bone and Bones,
pubmed-meshheading:18464016-Dose-Response Relationship, Drug,
pubmed-meshheading:18464016-Estetrol,
pubmed-meshheading:18464016-Female,
pubmed-meshheading:18464016-Injections, Subcutaneous,
pubmed-meshheading:18464016-Intestinal Absorption,
pubmed-meshheading:18464016-Osteocalcin,
pubmed-meshheading:18464016-Ovariectomy,
pubmed-meshheading:18464016-Random Allocation,
pubmed-meshheading:18464016-Rats,
pubmed-meshheading:18464016-Rats, Sprague-Dawley
|
pubmed:year |
2008
|
pubmed:articleTitle |
Oral bioavailability and bone-sparing effects of estetrol in an osteoporosis model.
|
pubmed:affiliation |
Pantarhei Bioscience, Zeist, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|